Day: October 30, 2025

LA PALMA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Liminatus Pharma, Inc. (NASDAQ: LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum of Understanding (MOU) with Capital Trust Group Limited (CTG), a New Zealand-based investment management firm, for a USD 30,000,000 equity financing via an earn-out mechanism to support Liminatus’s research and development of advanced immunotherapy assets. Subject to completion of diligence and the negotiation of definitive agreements, CTG intends to subscribe to newly issued shares of Liminatus, subject to compliance with Nasdaq listing rules and U.S. securities laws. The subscription funds are expected to be remitted following the submission and effectiveness of a registration statement relating...

Includes next-gen WiFi 7 technology and our best equipment to power Canadians’ connected homes TORONTO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Rogers today announced that Rogers Xfinity is bringing next-generation WiFi to more Canadians with Rogers Xfinity Pro. Our most elevated WiFi experience, available as an optional add-on for all Rogers Xfinity Internet plans, includes an upgrade to our best-in-class WiFi 7-enabled gateway with device prioritization and WiFi back up with Storm Ready WiFi to keep customers connected through the unexpected. “Canadians deserve the best internet experience and Rogers Xfinity Pro brings customers our most powerful gateway yet, with next-generation WiFi 7, and features they can’t get anywhere else,” said Bret Leech, President, Residential, Rogers. “With Rogers Xfinity Pro, customers get our best equipment...

HERZLIYA, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced that it will release its earnings for the third quarter of 2025 on Wednesday, November 19, 2025, before U.S. markets open. Nayax will hold two calls, one in English and one in Hebrew. Nayax CEO and Chairman, Yair Nechmad, will speak alongside Nayax’s Chief Financial Officer, Sagit Manor. Conference Calls: The conference call in English will be held at: 8:30 a.m. Eastern Time / 3:30 p.m. Israel Time / 5:30 a.m. Pacific Time. The conference call in Hebrew will be held at:9:30 a.m. Eastern Time / 4:30 p.m. Israel time / 6:30 a.m. Pacific Time. For the conference call in English, we...

MONTRÉAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — Air Canada was voted the North American Winner for Employee Experience Strategy in the sixth annual ARCET Global Customer Centricity World Series Awards. The awards celebrate companies from around the world for superior customer and employee experiences, and Air Canada was recognized for its innovative “Care & Class” initiative.“We are incredibly honoured that Air Canada’s “Care & Class” initiative has captured global recognition so early on. This brings a great deal of momentum to the work that our teams are delivering as we begin expanding it to Air Canada’s three Canadian hubs as well as across North American airports,” said Tom Stevens, Vice President, Customer Experience and Service Operations at Air Canada. “Our goal is to deliver an elevated level of personal care to...

Neve Yarak, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, recently announced the closing of the merger with MitoCareX Bio Ltd. (“MitoCareX”), a biotech company focused on drug discovery targeting cancer therapeutics, with a range of other potential diseases and disorders, through targeting the mitochondrial SLC25 protein family. MitoCareX is focusing on the development of novel therapies for hard-to-treat cancers by targeting proteins belonging to the mitochondrial SLC25 protein family. Central to this effort is MITOLINE™, MitoCareX’s proprietary algorithm that enables reliable 3D comparative modeling of mitochondrial SLC25’s proteins, which further allows the...

MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations, will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal...

GRAND JUNCTION, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) — ProStar® Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS, OTCQX: MAPPF, FSE: 5D00), developer of PointMan® Precision Mapping Solutions® and LinQD™ enterprise integration platform, is pleased to announce a strategic alliance with Premium Positioning, a leader in multi-network GNSS correction services in delivering high-precision positioning services that provide reliable, centimeter-level accuracy throughout Europe, Latin America, North America and Australia. This alliance integrates Premium Positioning’s advanced RTK Premium multi-network service with ProStar’s PointMan and LinQD platforms to deliver a unified precision mapping and data exchange ecosystem for the infrastructure and utility sectors. Together, the companies will provide real-time, high-accuracy...

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 30 OCTOBER 2025 AT 15.16 P.M. INSIDE INFORMATION Inside information: Oma Savings Bank Plc discontinues the IRB application process and does not seek IRB permit in the near future The Board of Directors of Oma Savings Bank Plc (OmaSp or the Company) announced in November 2024 the suspense of the IRB application process until further notice, and the evaluation of the IRB model framework development needs and a possible submission of a new IRB application separately. The Company has re-evaluated the benefits of IRB approach against the current loan portfolio of OmaSp, which has significantly changed since the start of the project. In addition, the benefits of IRB approach have been re-evaluated more accurately than before by taking into account the new capital requirements regulation that entered...

Selects Greenstone Biosciences to Accelerate AI-Driven iPSC Precision Medicine Platform PHOENIX, Oct. 30, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of its BioDefense Inc. Veterans Initiative, believed to be a first-of-its-kind national program to combat the devastating long-term effects of toxic burn pit exposure among U.S. service members. This initiative underscores the Company’s commitment to establishing a mission-critical role in America’s biodefense infrastructure by positioning Creative Medical as a cornerstone of national medical readiness and veteran health security. The program will utilize Creative Medical’s proprietary iPSC and regenerative...

Tori Spelling shares her and her family’s journey with eczema and seborrheic dermatitis to encourage others to take control of their skin health ZORYVE® (roflumilast) is the #1 prescribed branded topical therapy for three major inflammatory skin conditions combined – eczema, plaque psoriasis, and seborrheic dermatitisWESTLAKE VILLAGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the Free to Be Me awareness campaign featuring actress Tori Spelling, and her daughter, Stella (17). The campaign aims to shed light on the emotional and physical burden of inflammatory skin diseases for the approximately 36 million Americans living with conditions such as atopic dermatitis...